Biomedical Engineering and Bioengineering Commons^™

Neomycin-Enhanced Carbodiimide Cross-Linking For Glycosaminoglycan Stability In Bioprosthetic Heart Valves, Joshua Leong

All Theses

Valvular heart diseases lead to over 290,000 heart valve replacements worldwide each year, and approximately half of these involve replacement with a bioprosthetic heart valve (BHV) [1]. BHVs exhibit excellent hemocompatibility, but suffer from inadequate long-term durability with most adult implanted valves failing within 12 to 15 years after implantation [2]. Although this may be adequate for some individuals, BHV implantation may be contraindicated in younger individuals to avoid reoperation. Even in elder recipients, valve dysfunction can still cause death or reoperation that could be avoided with increased BHV durability. Therefore, investigation into methods of increasing BHV durability can not …